Clinical and prognostic features of patients with detailed RAS/BRAF-mutant colorectal cancer in Japan | BMC Cancer | Full Text
Can KRAS Positive Colorectal and Lung Cancer Finally be Targeted? - CancerConnect
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database in: Journal of the National Comprehensive Cancer Network Volume 19 Issue 3 (2021)
Life | Free Full-Text | Integrated Decision-Making in the Treatment of Colon-Rectal Cancer: The Case of KRAS-Mutated Tumors
KRAS and extended RAS molecular profiling in metastatic colorectal cancer | Colorectal Cancer
Cancers | Free Full-Text | Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer
IJMS | Free Full-Text | Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX | Scientific Reports
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers - ScienceDirect
Frequencies of KRAS mutations measured using methods with different... | Download Scientific Diagram
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
KRas mutations spectrum in 670 colorectal cancers | Download Table
Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer | BMC Cancer | Full Text
,0.jpg "Progress towards individualized treatment of colorectal cancer UAB Barcelona")
Progress towards individualized treatment of colorectal cancer UAB Barcelona
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
Immune modulatory effects of oncogenic KRAS in cancer | Nature Communications
Prevalence of KRAS, NRAS and BRAF mutations in patients with colorectal... | Download Scientific Diagram
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer
KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy | Annals of Surgical Oncology
Clinical characteristics and prognostic value of the KRAS mutation in Chinese colorectal cancer patients - Ye Yuan, Yingting Liu, Ye Wu, Junling Zhang, Chunti Shen, Feng Zhang, Changping Wu, Wenwei Hu, 2021
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study - Chida - 2021 - The Oncologist - Wiley Online Library
